Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 81

1.

Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma.

Bougnaud S, Golebiewska A, Oudin A, Keunen O, Harter PN, Mäder L, Azuaje F, Fritah S, Stieber D, Kaoma T, Vallar L, Brons NH, Daubon T, Miletic H, Sundstrøm T, Herold-Mende C, Mittelbronn M, Bjerkvig R, Niclou SP.

Oncotarget. 2016 Mar 25. doi: 10.18632/oncotarget.7454. [Epub ahead of print]

2.

Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma.

Azuaje F, Tiemann K, Niclou SP.

Cell Commun Signal. 2015 Mar 31;13:23. doi: 10.1186/s12964-015-0098-6. Review.

3.

A gene mapping bottleneck in the translational route from zebrafish to human.

de Klein N, Ibberson M, Crespo I, Rodius S, Azuaje F.

Front Genet. 2015 Jan 12;5:470. doi: 10.3389/fgene.2014.00470. eCollection 2014.

4.

Databases for lncRNAs: a comparative evaluation of emerging tools.

Fritah S, Niclou SP, Azuaje F.

RNA. 2014 Nov;20(11):1655-65. doi: 10.1261/rna.044040.113. Review.

5.

Permanent culture of macrophages at physiological oxygen attenuates the antioxidant and immunomodulatory properties of dimethyl fumarate.

Haas B, Chrusciel S, Fayad-Kobeissi S, Dubois-Randé JL, Azuaje F, Boczkowski J, Motterlini R, Foresti R.

J Cell Physiol. 2015 May;230(5):1128-38. doi: 10.1002/jcp.24844.

PMID:
25303683
6.

Transcriptional response to cardiac injury in the zebrafish: systematic identification of genes with highly concordant activity across in vivo models.

Rodius S, Nazarov PV, Nepomuceno-Chamorro IA, Jeanty C, González-Rosa JM, Ibberson M, da Costa RM, Xenarios I, Mercader N, Azuaje F.

BMC Genomics. 2014 Oct 3;15:852. doi: 10.1186/1471-2164-15-852.

7.

Modeling tumor heterogeneity and predicting effective combined therapies through computational optimization algorithms.

Azuaje FJ.

Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):E4287. doi: 10.1073/pnas.1414893111. Epub 2014 Sep 24. No abstract available.

8.

Selecting biologically informative genes in co-expression networks with a centrality score.

Azuaje FJ.

Biol Direct. 2014 Jun 19;9:12. doi: 10.1186/1745-6150-9-12.

9.

Linking biochemical pathways and networks to adverse drug reactions.

Zheng H, Wang H, Xu H, Wu Y, Zhao Z, Azuaje F.

IEEE Trans Nanobioscience. 2014 Jun;13(2):131-7. doi: 10.1109/TNB.2014.2319158.

PMID:
24893363
10.

An information theoretic approach to assessing Gene-Ontology-driven similarity and its application.

Wang H, Azuaje F, Zheng H.

Int J Data Min Bioinform. 2014;9(2):121-34.

PMID:
24864374
11.

Meeting highlights from the 2013 European Society of Cardiology Heart Failure Association Winter Meeting on Translational Heart Failure Research.

Hohl M, Ardehali H, Azuaje FJ, Breckenridge RA, Doehner W, Eaton P, Ehret GB, Fujita T, Gaetani R, Giacca M, Hasenfuß G, Heymans S, Leite-Moreira AF, Linke WA, Linz D, Lyon A, Mamas MA, Orešič M, Papp Z, Pedrazzini T, Piepoli M, Prosser B, Rizzuto R, Tarone G, Tian R, van Craenenbroeck E, van Rooij E, Wai T, Weiss G, Maack C.

Eur J Heart Fail. 2014 Jan;16(1):6-14. doi: 10.1002/ejhf.10. Epub 2013 Dec 14. Review. No abstract available.

12.

Drug-domain interaction networks in myocardial infarction.

Wang H, Zheng H, Azuaje F, Zhao XM.

IEEE Trans Nanobioscience. 2013 Sep;12(3):182-8. doi: 10.1109/TNB.2013.2263556. Epub 2013 Aug 19.

PMID:
23974657
13.

Analysis of a gene co-expression network establishes robust association between Col5a2 and ischemic heart disease.

Azuaje F, Zhang L, Jeanty C, Puhl SL, Rodius S, Wagner DR.

BMC Med Genomics. 2013 Apr 10;6:13. doi: 10.1186/1755-8794-6-13.

14.

Drug interaction networks: an introduction to translational and clinical applications.

Azuaje F.

Cardiovasc Res. 2013 Mar 15;97(4):631-41. doi: 10.1093/cvr/cvs289. Epub 2012 Sep 12. Review.

15.

Systems-based approaches to cardiovascular biomarker discovery.

Azuaje FJ, Dewey FE, Brutsaert DL, Devaux Y, Ashley EA, Wagner DR.

Circ Cardiovasc Genet. 2012 Jun;5(3):360-7. doi: 10.1161/CIRCGENETICS.112.962977. No abstract available.

16.

Low levels of vascular endothelial growth factor B predict left ventricular remodeling after acute myocardial infarction.

Devaux Y, Vausort M, Azuaje F, Vaillant M, Lair ML, Gayat E, Lassus J, Ng LL, Kelly D, Wagner DR, Squire IB.

J Card Fail. 2012 Apr;18(4):330-7. doi: 10.1016/j.cardfail.2012.01.010. Epub 2012 Feb 2.

PMID:
22464775
17.

Bioinformatics as a driver, not a passenger, of translational biomedical research: Perspectives from the 6th Benelux bioinformatics conference.

Azuaje FJ, Heymann M, Ternes AM, Wienecke-Baldacchino A, Struck D, Moes D, Schneider R.

J Clin Bioinforma. 2012 Mar 13;2:7. doi: 10.1186/2043-9113-2-7.

18.

Prediction of adverse cardiovascular events of noncardiovascular drugs through drug-target interaction networks.

Azuaje FJ, Devaux Y, Wagner DR.

Clin Transl Sci. 2012 Feb;5(1):111. doi: 10.1111/j.1752-8062.2011.00367.x. Epub 2012 Jan 10. No abstract available.

PMID:
22376268
19.

Drug-target network in myocardial infarction reveals multiple side effects of unrelated drugs.

Azuaje FJ, Zhang L, Devaux Y, Wagner DR.

Sci Rep. 2011;1:52. doi: 10.1038/srep00052. Epub 2011 Aug 2.

20.

Use of circulating microRNAs to diagnose acute myocardial infarction.

Devaux Y, Vausort M, Goretti E, Nazarov PV, Azuaje F, Gilson G, Corsten MF, Schroen B, Lair ML, Heymans S, Wagner DR.

Clin Chem. 2012 Mar;58(3):559-67. doi: 10.1373/clinchem.2011.173823. Epub 2012 Jan 17.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk